Cryptopharmaceuticals & personalised drug delivery systems to dramatically change pharma manufacturing & distribution

pharma

Digitalization in the medical field opens up new opportunities for personalized pharmaceuticals as well. 3D Printing techniques are creating great opportunities for personalised drug delivery systems. Drug dosage form production and manufacture will be dramatically changed once the problems of right materials and regulatory issues are solved. But what is the current status? Where are we now, what are the most challenging issues we are confronted with and what are the next steps?

Continue reading “Cryptopharmaceuticals & personalised drug delivery systems to dramatically change pharma manufacturing & distribution”

Printing medical devices under the MDR: changed world?

Jan-Paul van Loon

by Jan-Paul van Loon, Qserve Consultancy BV

On May 26, 2020, the new Medical Device Regulation (MDR) will come into force, and Hospitals and Industry are getting increasingly nervous as this date approaches. Although the MDR is not particularly stricter than the current Medical Device Directive (MDD) for custom-made device manufacturers, there are differences, as for example the necessity of a “Person Responsible for Regulatory Compliance”, and more extensive Post-Market Surveillance requirements.

Continue reading “Printing medical devices under the MDR: changed world?”